Abstract:OBJECTIVE:To suppress the expression of CCR5 and CXCR4, the co-receptors for human immunodeficiency virus type 1 ( HIV-1), and thus inhibit HIV-1 from entering cells.METHODS:DNA fragments encoding either CCR5 or CXCR4 were amplified from healthy human peripheral blood mononuclear cells (PBMCs) by reverse transcript polymerase chain reaction (RT-PCR) and sequencing was performed. Correct fragments were inserted into Shuttle plasmid inversely, which was recombined with backbone plasmid containing homologous adenoviral genome in E. coli BJ5183. The recombinant plasmids were transfected into 293 cells in which they were packaged and amplified. Recombinant adenoviruses containing antisense RNA of CCR5 or CXCR4 were obtained and identified by RT-PCR, and the titres of them were determined by cytopathic effect (CPE) method. The U937 and MT4 cells were infected by recombinant adenoviruses containing antisense RNA of CCR5 (multiplicity of infection, MOI = 100) and CXCR4 (MOI = 200), respectively. The expression of co-receptors on infected cell was measured by fluorescence activated cell sorter at 24, 48, 72 hours and 10 days after infection. In addition, the chemotactic activity and proliferation of infected cells were detected with Boyden chamber and 3H incorporation respectively.RESULTS:We constructed the recombinant plasmids and obtained the recombinant adenoviruses which contained antisense RNA of CCR5 or CXCR4 and were designated as pAd-antiR5 and pAd-antiX4 respectively. The titers of recombinant adenoviruses pAd-antiR5 and pAd-antiX4 were 5 x 10" PFU/ml and 7 x 10(10) PFU/ml, respectively. The expression rate of CCR5 on U937 cells decreased from 82. 10% (blank control) to 1.12% (Ad-antiR5 infected) , and that of CXCR4 on MT4 cells decreased from 42% (blank control) to 1.03% (Ad-antiX4 infected) 24 hours later. The expression rates of CCR5 on Ad-antiR5 infected U937 cells were 1.02% , 1.26% , 1.23% at 48 hours, 72 hours, and 10 days later, respectively. The expression rates of CXCR4 on Ad-antiX4 infected MT4 cells were 1.13%, 1.17%, 1.22% at 48 hours, 72 hours, and 10 days later, respectively. Moreover, the recombinant adenovirus had no effects on chemotactic activity and proliferation of the cells.CONCLUSION:The recombinant adenovirus containing antisense CCR5 or CXCR4 can remarkably decrease the expression of co-receptors for HIV-1 on U937 or MT4 cells without affecting their chemotactic activities and proliferative abilities.

Inhibition of CXCR4 Expression by Recombinant Adenoviruses Containing Anti-Sense RNA Resists HIV-1 Infection on MT4 Cell Lines.

Inhibition of Expression of CCR5 and CXCR4 on Cells by Adenovirus-mediated Antisense RNA

Down-regulation of CXCR4 Expression in MT4 Cells by a Recombinant Vector Expressing Antisense RNA to CXCR4 and Its Potential Anti-Hiv-1 Effect.

Genome Editing of CXCR4 by CRISPR/cas9 Confers Cells Resistant to HIV-1 Infection.

Downregulation of CCR5 expression on cells by recombinant adenovirus containing antisense CCR5, a possible measure to prevent HIV-1 from entering target cells.

Genome Modification of CXCR4 by Staphylococcus Aureus Cas9 Renders Cells Resistance to HIV-1 Infection.

HIV-1 Inhibition in Cells with CXCR4 Mutant Genome Created by CRISPR-Cas9 and Piggybac Recombinant Technologies.

Construction and Purification of the Recombinant Adenoviral Vector Carrying Antisense RNA to Chemokine Receptor CCR5

Construction of Recombinant Vectors Expressing Antisense RNA to CCR5 and Expression in Eukaryotic Cells

A Novel CXCR4 Targeting Protein SDF-1/54 As an HIV-1 Entry Inhibitor.

Intracellular Expression of Multimerized Antisense TAR-Core RNAs Inhibit the Replication of Human Immunodeficiency Virus Type 1 in Human CD4+ T Lymphocytes.

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

CCR5 Editing by Staphylococcus Aureus Cas9 in Human Primary CD4+ T Cells and Hematopoietic Stem/progenitor Cells Promotes HIV-1 Resistance and CD4+ T Cell Enrichment in Humanized Mice

124 CCR6 Ligands Inhibit HIV in Highly Susceptible CD4+CCR6+ T Cells by Inducing APOBEC3G Expression

Construction and Expression of Small Interfering RNA Expression Vector of CXCR4

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

A Novel Approach to Block HIV-1 Coreceptor CXCR4 in Non-Toxic Manner.

RNA Interfering of CXCR4 Inhibits the Adhesion, Invasion, and Tumorigenicity of Acute Monocytic Leukemic Cells in Vivo.

Zinc-finger Nuclease Editing of Human Cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and Enrichment

Down-regulation of CXCR4 expression by SDF-KDEL in CD34+ hematopoietic stem cells: An anti-human immunodeficiency virus strategy

Hiv-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of Cxcr4 Virus Post Haart?